Search Results - Sato G
- Showing 1 - 4 results of 4
-
1
-
2
Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study by Itsukaichi A, Yoshikawa F, Fuchigami A, Iwata Y, Sato G, Miyagi M, Hirose T, Uchino H
Published in Diabetes, Metabolic Syndrome and Obesity (2025-01-01)Get full text
Article -
3
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum] by Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Published in Diabetes, Metabolic Syndrome and Obesity (2021-07-01)Get full text
Article -
4
Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study by Saito M, Uchino H, Iwata Y, Fuchigami A, Sato G, Yoshikawa F, Miyagi M, Miyazaki T, Urita Y, Aoki K, Ishii Y, Tateda K, Hirose T
Published in Diabetes, Metabolic Syndrome and Obesity (2024-06-01)Get full text
Article
